ESR2 and lung carcinoma: Interestingly, the novel G-protein-coupled estrogen receptor 1(GPER1), which is distinct from ER−α and ER−β because it can bind E2 with high affinity and transduces rapid nongenomic signaling, has also been shown to have higher expression levels in lung carcinoma than in normal lung tissues.